Delivery Order SPE2DB22D1103-SPE2DB25FTNS3
- Not listed
- The Defense Logistics Agency awarded a $3,157.92 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count). This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on September 9, 2025, valued at $1,227.09 for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in unit dose packages of 30. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of September 10, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $2,314.14 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30-count packages). The contract, executed on August 18, 2025, with an ultimate completion date of August 19, 2025, is structured as a firm fixed price delivery order with no set-aside designation. This award represents a competitive procurement under AmerisourceBergen's existing Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $3,549.93 delivery order to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 80-25 mg tablets (30-count unit dose packaging) on August 19, 2025, with completion scheduled for August 20, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The delivery location is specified as Conshohocken, PA, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $4,070.31 to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 80-25 mg tablets in unit-dose packaging (30-count), with an ultimate completion date of September 16, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order valued at $5,083.49 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in unit dose packaging (30 count) under a firm fixed price contract. This delivery order, which was competitively awarded with no set-aside designation, was executed on July 23, 2025, with an ultimate completion date of July 24, 2025. Performance will take place at the contractor's Corporate Office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $3,021.94 to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 80-12.5 mg tablets, 30-count unit dose packages. This competitively awarded, firm fixed-price delivery order was executed on June 23, 2025, with an ultimate completion date of June 24, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the company's competitive standing in...
- The Defense Logistics Agency awarded a delivery order valued at $29,770.38 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in unit dose packaging (30 count) on September 19, 2025, with completion scheduled for September 22, 2025. This delivery order was issued as a firm fixed price contract with no set-aside designation, utilizing open competition. The pharmaceutical product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30 count), valued at $15,288.87. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 19, 2025. This order is...
- The Defense Logistics Agency awarded a delivery order valued at $5,086.20 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30 count) on July 30, 2025, with completion targeted for July 31, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FTNS3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30 count) valued at $7,988.25. This is a firm fixed price delivery order with an ultimate completion date of June 3, 2025, and represents a non-competitive award. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards predominantly with the Defense Logistics Agency's Medical Supply Chain, supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The delivery order for Telmisartan-HCTZ, an antihypertensive combination medication, exemplifies the company's role in providing essential pharmaceuticals to support Defense Health Agency operations and other government healthcare systems. All reviewed contract awards demonstrate AmerisourceBergen's capability to meet federal procurement requirements through competitive processes, with delivery orders typically structured as firm fixed price arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 6/2/25 |